Free Trial
NYSEAMERICAN:BDR

Blonder Tongue Laboratories (BDR) Stock Price, News & Analysis

Blonder Tongue Laboratories logo

About Blonder Tongue Laboratories Stock (NYSEAMERICAN:BDR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
190,300 shs
Average Volume
364,033 shs
Market Capitalization
$4.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blonder Tongue Laboratories and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BDR Stock News Headlines

Blonder Tongue Laboratories Inc.
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
How the colour of your tongue reveals your health
Abbott Laboratories BDR (ABTT34)
Forest Laboratories
See More Headlines

BDR Stock Analysis - Frequently Asked Questions

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) announced its quarterly earnings data on Friday, May, 15th. The technology company reported ($0.21) EPS for the quarter. The technology company had revenue of $4.05 million for the quarter. Blonder Tongue Laboratories had a negative net margin of 8.71% and a negative trailing twelve-month return on equity of 56.15%.

Shares of BDR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Blonder Tongue Laboratories investors own include iBio (IBIO), VBI Vaccines (VBIV), Vaxart (VXRT), Nokia (NOK), Onconova Therapeutics (ONTX), Senseonics (SENS) and Agile Therapeutics (AGRX).

Company Calendar

Last Earnings
5/15/2020
Today
9/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Radio & TV Communication Equipment
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:BDR
CIK
1000683
Employees
85
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.47 million
Net Margins
-8.71%
Pretax Margin
-8.62%
Return on Equity
-56.15%
Return on Assets
-12.11%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.35
Quick Ratio
0.63

Sales & Book Value

Annual Sales
$16.38 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
13,326,000
Free Float
5,337,000
Market Cap
$4.06 million
Optionable
Not Optionable
Beta
0.23
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSEAMERICAN:BDR) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners